In the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) was a top performer, from both a share-price and an ...

The S&P 500 gained 0.6% on Monday, March 31, boosted by an afternoon rally even as investors brace for the planned onset of reciprocal tariffs later this week.

The regulator was at odds with the new HHS secretary's stance on vaccines. Moderna's vaccine development pipeline could be affected. The vaccine maker's shares tumbled following the resignation of ...

Under emergency use, vaccines can be removed even after a health emergency is considered to be over. Full approval from the ...

Furthering its goal to grow the reach of its mRNA vaccines and guard against future pandemics, Moderna cleared a key ...